Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Eloralintide

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight

Eli Lilly · Phase 1 · Recruiting · Enrollment 56

NCT07738614

ArmPopulationDoseWeeksEstimandWeight change
Eloralintide Cohort 1Obesity or overweightn/rn/rn/rn/r
Eloralintide Cohort 2Obesity or overweightn/rn/rn/rn/r
Eloralintide Cohort 3Obesity or overweightn/rn/rn/rn/r
Eloralintide Cohort 4Obesity or overweightn/rn/rn/rn/r
PlaceboObesity or overweightn/rn/rn/rn/r